Who
Carolyn E. Taylor
Director
Company insider
Files Form 4 as: Director, Tonix Pharmaceuticals Holding.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 0
- Bought
- $45K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Jul 2021
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Aug 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $15K1,415 at $10.55 | filing |
| 12 Jun 2026filed 15 Jun 2026 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $15K1,415 at $10.55 | filing |
| 12 May 2026filed 14 May 2026 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 21 Aug 2025filed 21 Aug 2025 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $15K418 at $36.03 | filing |
| 13 May 2025filed 15 May 2025 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 23 May 2024filed 24 May 2024 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,621 at $0.00 | filing |
| 8 May 2023filed 10 May 2023 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 9 May 2022filed 11 May 2022 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,131,500 at $0.00 | filing |
| 16 Jul 2021filed 27 Jul 2021 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —237,437 at $0.00 | filing |
News
Tonix Pharmaceuticals Sets 2027 Phase 1 Target For TNX-801 Vaccine CandidateTNXP · rttnews.com · 15 Oct 2026Tonix Pharmaceuticals Begins Building Lyme Disease Drug Facility in Hamilton, MontanaTNXP · matr.net · 12 Oct 2026
0 headlines in the last 90 days name Carolyn E. Taylor; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.